David Brindley

Chevron down

Regenerative Medicine: Hype, Hope and Emerging Clinical Realities

David is an international thought-leader in healthcare risk management, with a particular interest in regenerative medicines. His multi-disciplinary research seeks to evaluate and develop systematic, rigorous and transparent risk management tools supporting the translation of life-science innovations into commercially viable products and services.

Buttontwitter Buttonlinkedin

As Featured In

Original
Original
Original
Original
Original
Original

Partners & Attendees

Intel.001
Nvidia.001
Ibm watson health 3.001
Acc1.001
Rbc research.001
Twentybn.001
Mit tech review.001
Kd nuggets.001
Facebook.001
Maluuba 2017.001
Graphcoreai.001
Forbes.001
This website uses cookies to ensure you get the best experience. Learn more